IMRX · Immuneering Corp
United States · RS rating 25 · As of 2026-11-03
| Price | 3.68 USD |
|---|---|
| 1-day change | +5.4% |
| RS rating (overall / 1M / 3M / 12M) | 25 / 37 / 36 / 23 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 31 / 6 / 47 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +52.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +55.8% |
| Market cap (USD) | $396.6M |